After decades of orthodoxy and stringent enforcement of drug policies, the global counternarcotics regime is increasingly challenged. Some countries, particularly in the Americas and in Europe, are adopting liberalized approaches, and an array of drug policies is emerging. Policymakers are reviewing the effectiveness of existing policies and exploring alternatives, creating new directions for the global drug policy regime.
The Latin America Initiative (LAI) at Brookings, the London School of Economics (LSE), and the Open Society Foundations will host a discussion on global drug policy trends and effectiveness. Experts will address among other issues the security and organized crime implications, the effectiveness of supply-side policies, as well as mass incarceration and the public health dimensions.
After the program, panelists will take audience questions.
Panelists
- John Collins is international drug policy coordinator at LSE IDEAS.
- Vanda Felbab-Brown is senior fellow with the Center for 21st Century Security and Intelligence at Brookings.
- Daniel Mejia is associate professor and director of the Research Center on Drugs and Security at Universidad de los Andes.
- Jasmine Tylor is senior policy analyst at the Open Society Foundations.
- Harold Trinkunas (moderator) is senior fellow and director of the Latin America Initiative.